Siren »

Syros Pharmaceuticals shares owned by Siren

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Siren from 13F filings

Historical chart of Siren investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6M 2.6M 2.15

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Syros Pharmaceuticals

Bain Capital Life Sciences Investors
Siren
Samsara BioCapital
Point72 Asset Management
Flagship Ventures Management
Affinity Asset Advisors
Avidity Partners Management
Vanguard Group
Deep Track Capital
Opaleye Management
Blue Owl Capital Holdings
Kennedy Capital Management
ExodusPoint Capital Management
Exome Asset Management
Goldman Sachs Group

View all funds holding Syros Pharmaceuticals